Zepbound is a prescription drug used to help manage weight loss in certain adults. It can also be used to treat obstructive sleep apnea in adults with obesity. Two studies in the SURMOUNT trials ...
Early results have been striking. In a phase 2 trial, participants taking the highest dose lost nearly one-quarter of their body weight in less than a year. Researchers continue to study its safety, ...
U.S. News reviewed telehealth platforms that offer GLP-1 medications, some of which may provide both FDA-approved medications as well as compounded medications. Compounded medications have not ...
Not losing weight on Zepbound may be related to not yet reaching the highest maintenance dose for your body, or to not increasing your activity level. You may not lose a significant amount of weight ...
Update History2026/10/09 Article publishedIntroductionHello everyone!Do you ever find yourself wondering what the name of a ...
Maggie Aime has over 25 years of experience in healthcare and as a nurse across specialties including oncology, kidney transplant, cardiology, and more. She leverages her rich healthcare experience to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
We believe flexible dosing approaches will provide both patients and their providers with new options for improving long-term adherence to therapy and sustained weight management, both of which are ...
Two key factors suggest VK2735 could carve out a very profitable share of the market. The first is that it's being developed as a dual formulation therapy, opening up the possibility of initial weight ...
Jakob Roze, CSCS, is a health writer and high-end personal trainer. He is the founder and CEO of RozeFit, a high-end concierge personal training practice and online blog. Free weights and machines are ...
The 'Fast Money' traders talk the state of the weight loss trade. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this ...
Hosted on MSN
Weight loss drug: Viking Therapeutics says lead obesity drug shows weight retention with less frequent dosing
Viking Therapeutics Inc. VKTX stock surged on Tuesday after the company released positive topline results from its much-anticipated VK2735 maintenance trial. The dual GLP-1 and GIP receptor agonist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results